Dartmouth College nRichDx Targets Liquid Biopsy Space With Magnetic Sample Prep Platform Premium The Irvine, California-based firm said its "Revolution" system offer recovery rates of 70 to 90 percent across a wide range of liquid sample volumes. Biocartis Microsatellite Instability Assay Validated by MSKCC, Dartmouth Researchers Premium Researchers separately found that the assay had high concordance with other techniques in cancers including colorectal and endometrial carcinomas. Dartmouth-Led Team Wins $12.1M NIH Grant for Lung Cancer Research Using the grant funding, the investigators are aiming to advance the precision diagnosis and treatment of lung cancer. New Lung Cancer Susceptibility Loci Discovered in GWAS With genotyping data from tens of thousands of individuals with or without lung cancer, researchers identified eight known and 10 new loci associated with lung cancer. NanoString Seeks to Supplant qPCR With New Low-Plex, High-Throughput Reagents Premium The firm envisions applying its new PlexSet technology to the upper end of multiplex gene expression analysis as well as CRISPR validation applications. Nov 28, 2016 Epigenetic Markers in Glioblastoma Linked to Poor Prognosis Mar 3, 2016 GWAS Leads to Potential TB Resistance Locus Oct 19, 2010 Small RNA Sequencing Study Offers Peek into Vertebrate Evolution Sep 17, 2010 Dartmouth, UNH Win $15.4M INBRE Funding Sep 24, 2009 Q&A: Dartmouth's Kevin Peterson Discusses miRNAs and Annelid Phylogenetics Premium Feb 2, 2009 BioRegion Newsmakers: Feb 2, 2009 Premium Breaking News FDA Revises SARS-CoV-2 Test Emergency Use Authorization Requirements to Account for Variants Geisinger Wins $5M NIH Grant to Develop Point-of-Care Genetic Diagnostic Tool Second Genome, Virginia Commonwealth University Partner on NASH Biomarker Discovery LGC Receives CE Mark for AccuPlex SARS-CoV-2, Flu A/B, RSV Reference Material Kit Esophageal Cancer Testing Firm Lucid Diagnostics Files For IPO Twist Bioscience, DeepCDR Collaborate on Antibody Library Design The Scan Booster for At-Risk The New York Times reports that the US Food and Drug Administration has authorized a third dose of the Pfizer-BioNTech SARS-CoV-2 vaccine for people over 65 or at increased risk. Preprints OK to Mention Again Nature News reports the Australian Research Council has changed its new policy and now allows preprints to be cited in grant applications. Hundreds of Millions More to Share The US plans to purchase and donate 500 million additional SARS-CoV-2 vaccine doses, according to the Washington Post. Nature Papers Examine Molecular Program Differences Influencing Neural Cells, Population History of Polynesia In Nature this week: changes in molecular program during embryonic development leads to different neural cell types, and more.